Green tea consumption and breast cancer risk or recurrence: a meta-analysis
- 1.5k Downloads
Green tea is a commonly consumed beverage in Asia and has been suggested to have anti-inflammatory and possible anti-carcinogenic properties in laboratory studies. We sought to examine the association between green tea consumption and risk of breast cancer incidence or recurrence, using all available epidemiologic evidence to date. We conducted a systematic search of five databases and performed a meta-analysis of studies of breast cancer risk and recurrence published between 1998 and 2009, encompassing 5,617 cases of breast cancer. Summary relative risks (RR) were calculated using a fixed effects model, and tests of heterogeneity across combined studies were conducted. We identified two studies of breast cancer recurrence and seven studies of breast cancer incidence. Increased green tea consumption (more than three cups a day) was inversely associated with breast cancer recurrence (Pooled RR = 0.73, 95% CI: 0.56–0.96). An analysis of case–control studies of breast cancer incidence suggested an inverse association with a pooled RR of 0.81 (95% CI: 0.75, 0.88) while no association was found among cohort studies of breast cancer incidence. Combining all studies of breast cancer incidence resulted in significant heterogeneity. Available epidemiologic evidence supports the hypothesis that increased green tea consumption may be inversely associated with risk of breast cancer recurrence. The association between green tea consumption and breast cancer incidence remains unclear based on the current evidence.
KeywordsGreen tea Breast cancer Meta-analysis Systematic review Cancer incidence Cancer recurrence
Sources of support
Dr. Ogunleye is an Ekiti State of Nigeria Postgraduate Scholarship awardee.
- 1.Ries LAG, Melbert D, Krapcho M et al (eds) (2008) SEER Cancer Statistics Review, 1975–2005, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2005/, based on November 2007 SEER data submission, posted to the SEER web site
- 2.Parkin DM, Ferlay J, Hamdi-Cherif M et al (2003) Cancer in Africa—epidemiology and prevention. IARC Scientific Publications No 153, LyonGoogle Scholar
- 3.Ferlay J, Bray F, Pisani P, Parkin DM (2004) GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5. version 2.0. IARC Press, LyonGoogle Scholar
- 13.Mnich CD, Hoek KS, Virkki LV, Farkas A, Dudli C, Laine E, Urosevic M, Dummer R (2009) Green tea extract reduces induction of p53 and apoptosis in UVB-irradiated human skin independent of transcriptional controls. Exp Dermatol 18(1):69–77. doi: 10.1111/j.1600-0625.2008.00765.x CrossRefPubMedGoogle Scholar
- 14.Kim J, Zhang X, Rieger-Christ KM et al (2006) Suppression of Wnt signaling by the green tea compound (_)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells: Requirement of the transcriptional repressor HBP1. J Biol Chem 281:10865–10875. doi: 10.1074/jbc.M513378200 CrossRefPubMedGoogle Scholar
- 20.Inoue M, Tajima K, Mizutani M et al (2001) Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan. Cancer Lett 167:175–182. doi: 10.1016/S0304-3835(01)00486-4 CrossRefPubMedGoogle Scholar
- 23.Tao M, Liu D, Gao L, Jin F (2002) Association between green tea drinking and breast cancer risk. Tumor 22(3):11–15 (in Chinese)Google Scholar
- 25.Shrubsole MJ, Lu W, Chen Z et al (2009) Drinking green tea modestly reduces breast cancer risk. J Nutr 139:1–7Google Scholar
- 33.McLarty J, Bigelow R, Williams B et al (2007) Prostate cancer patients administered green tea polyphenols demonstrate a reduction in serum levels of HGF and VEGF, and tissue levels of phosphorylated c-Met and phosphorylated Akt. In: Proceedings of the 98th Annual Meeting of the American Association of Cancer Research, Los Angeles, CA, 14–17 Apr, AACR, 2007, Abstract nr 2657Google Scholar